References

  1. Janin P, Haillot O, Boutin JM, Lesourd B, et al, The frequency of surgery of benign prostatic hypertrophy. Prog Urol. 1995. 5(4): 515-21. PubMed | Google Scholar

  2. Lebdai S, Robert G, Devonnec M, Fourmarier M, Haillot O,, et al. Management of patients under anticoagulants for transurethral resection of the prostate: a multicentric study by the CTMH-AFU. Prog Urol. 2009: 19(8): 553-7. PubMed | Google Scholar

  3. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008: 180(1): 246-9. PubMed | Google Scholar

  4. Borboroglu PG, Kane CJ, Ward JF, et al. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol. 1999; 162(4): 1307-10. PubMed | Google Scholar

  5. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol.1989; 141(2): 243-7. PubMed | Google Scholar

  6. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006; 50(5): 969-79. PubMed | Google Scholar

  7. Costello AJ, Bowsher WG, Bolton DM, Braslis KG, al. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol. 1992; 69(6): 603-8. PubMed | Google Scholar

  8. Muschter R, A Hofstetter. Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol. 1995; 9(2): 129-35. PubMed | Google Scholar

  9. Bachmann A, Ruszat R, Wyler S, Reich O et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol. 2005; 47(6): 798-804. PubMed | Google Scholar

  10. Bachmann A, Schürch L, Ruszat R, Wyler SF, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005; 48(6): 965-71. PubMed | Google Scholar

  11. Sountoulides P, P Tsakiris.The evolution of KTP laser vaporization of the prostate. Yonsei Med J. 2008; 49(2): 189-99. PubMed | Google Scholar

  12. Tasci AI, Tugcu V, Sahin S, Zorluoglu F, et al. Rapid communication: photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol. 2008; 22(2): 347-53. PubMed | Google Scholar

  13. Tugcu V, Tasci AI, Sahin S, Ordekci Y, et al. Outcomes of 80 W KTP laser vaporization of the large prostate. Urol Int. 2007; 79(4): 316-20. PubMed | Google Scholar

  14. Volkan T, Ihsan TA, Yilmaz O, Emin O, et al. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol. 2005; 48(4): 608-13. PubMed | Google Scholar

  15. Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010;58(3): 349-55. PubMed | Google Scholar

  16. Capitán C, Blázquez C, Martin MD, Hernández V, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol.2011; 60(4): 734-9. PubMed | Google Scholar

  17. Tasçi AI, Ilbey YÖ, Luleci H, Cicekler O, et al. 120-W GreenLight laser photoselective vaporization of prostate for benign prostatic hyperplasia: midterm outcomes. Urology. 2011;78(1): 134-40. PubMed | Google Scholar

  18. Mentine N, Boukaidi SA, Loeffler Mac-Neill J, et al. Photovaporisation of the prostate using KTP laser in patients on antithrombotics. About a restrospective study of 120 cases. Prog Urol. 2013; 23(2): 137-43. PubMed | Google Scholar

  19. Ruszat R, Wyler S, Forster T, Reich O et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol. 2007; 51(4): 1031-8. PubMed | Google Scholar

  20. Tao W, Xue B, Zang Y, Sun C, et al. The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients. Lasers Med Sci. 2013; 28(4):1151-7. PubMed | Google Scholar

  21. Saklad M. Grading of Patients for Surgical Procedures. Anesthesiology. 1941; 2(3): 281-284. PubMed | Google Scholar

  22. Chakravarti A, S MacDermott. Transurethral resection of the prostate in the anticoagulated patient. Br J Urol. 1998; 81(4): 520-2. PubMed | Google Scholar

  23. Dotan ZA, Mor Y, Leibovitch I, Varon D, et al. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol. 2002; 168(2): 610-3. PubMed | Google Scholar

  24. Parr NJ, Loh CS, Desmond AD. Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy. Br J Urol. 1989; 64(6): 623-5. PubMed | Google Scholar

  25. Descazeaud A, Robert G, Lebdai S, Bougault A, et al. Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. World J Urol. 2011; 29(2): 211-6. PubMed | Google Scholar

  26. Okamura K, Nojiri Y, Seki N, Arai Y, et al. Perioperative management of transurethral surgery for benign prostatic hyperplasia: A nationwide survey in Japan. 2011. Japan. The Japanese Urological Association. PubMed | Google Scholar

  27. Sandhu JS, Ng CK, Gonzalez RR, et al. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol. 2005; 19(10): 1196-8. PubMed | Google Scholar

  28. Reich O, Bachmann A, Siebels M, Hofstetter A, et al. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol. 2005; 173(1): 158-60. PubMed | Google Scholar

  29. Yuan J, Wang H, Wu G, Liu H, et al. High-power (80 W) potassium titanyl phosphate laser prostatectomy in 128 high-risk patients. Postgrad Med J.2008; 84(987): 46-9. PubMed | Google Scholar

  30. Karatas OF, Alkan E, Horasanli K, Luleci H, et al. Photoselective vaporization of the prostate in men with a history of chronic oral anti-coagulation. Int Braz J Urol. 2010; 36(2): 190-7. PubMed | Google Scholar

  31. Woo H, Reich O, Bachmann A, Choi B et al. Outcome of GreenLight HPS 120-W Laser Therapy in Specific Patient Populations: Those in Retention, on Anticoagulants, and with Large Prostates (>/= 80ml). European Urology Supplements. 2008; 7(4): 378-383. PubMed | Google Scholar

  32. van Melick HH, van Venrooij GE, Boon TA. Laser prostatectomy in patients on anticoagulant therapy or with bleeding disorders. J Urol. 2003; 170(5): 1851-5. PubMed | Google Scholar

  33. Hai MA , RS Malek. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol. 2003; 17(2): 93-6. PubMed | Google Scholar

  34. Chung DE, Wysock JS, Lee RK, Melamed SR, et al. Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol. 2011; 186(3): 977-81. PubMed | Google Scholar